News

Gainesville, Fla. (Feb. 13, 2018) – Exactech (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, today announced that at…

Gainesville, Fla. (December 4, 2017) – Exactech, Inc. (Nasdaq: EXAC), a leading developer and producer of orthopaedic implant devices and surgical instrumentation for extremities and large joints, announced today that it has…

GAINESVILLE, Fla. (Oct. 30, 2017) — Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that…

Gainesville, Fla. (Oct. 25, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, announced today that,…

Leading Healthcare Investor Provides Company with Strategic Growth Capital Exactech Shareholders To Receive $42.00 Per Share In Cash Transaction Values Exactech at $625 Million Represents a Premium of Approximately 31%…

GAINESVILLE, Fla. (October 12, 2017) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products and biologic solutions for extremities, knee and hip, said today it…